The Alzheimer’s and Parkinson’s Diseases Conference (AD/PD) 2026, recently held in Copenhagen (Denmark) brought together over 5,800 delegates to discuss advances across neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and related disorders.
Key themes emerging from this year’s meeting included the shift towards earlier disease detection, the integration of artificial intelligence (AI) and real-world data, and the development of novel therapeutic approaches targeting underlying disease biology. TouchNeurology shares some highlighted sessions that took place at AD/PD this year on its online platform (free to register). See: https://touchneurology.com/insight/ad-pd-2026-highlights-advancing-early-detection-diagnostics-and-therapeutics-across-neurodegenerative-diseases/
